rs755534468
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The ENST00000334268.9(TRDN):āc.851C>Gā(p.Pro284Arg) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000107 in 1,396,074 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
ENST00000334268.9 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRDN | NM_006073.4 | c.851C>G | p.Pro284Arg | missense_variant, splice_region_variant | 9/41 | ENST00000334268.9 | NP_006064.2 | |
TRDN | NM_001251987.2 | c.851C>G | p.Pro284Arg | missense_variant, splice_region_variant | 9/21 | NP_001238916.1 | ||
TRDN | NM_001256020.2 | c.793+6524C>G | intron_variant | NP_001242949.1 | ||||
TRDN | NM_001407315.1 | c.793+6524C>G | intron_variant | NP_001394244.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRDN | ENST00000334268.9 | c.851C>G | p.Pro284Arg | missense_variant, splice_region_variant | 9/41 | 1 | NM_006073.4 | ENSP00000333984 | A2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000120 AC: 2AN: 166958Hom.: 0 AF XY: 0.0000112 AC XY: 1AN XY: 89620
GnomAD4 exome AF: 0.0000107 AC: 15AN: 1396074Hom.: 0 Cov.: 28 AF XY: 0.00000434 AC XY: 3AN XY: 690492
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Catecholaminergic polymorphic ventricular tachycardia 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 21, 2022 | This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 284 of the TRDN protein (p.Pro284Arg). This variant is present in population databases (rs755534468, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with TRDN-related conditions. ClinVar contains an entry for this variant (Variation ID: 532386). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 16, 2017 | The p.P284R variant (also known as c.851C>G), located in coding exon 9 of the TRDN gene, results from a C to G substitution at nucleotide position 851. The proline at codon 284 is replaced by arginine, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at